5.72
+0.56
+(10.85%)
At close: 4:00:01 PM EDT
5.72
0.00
(0.00%)
After hours: 4:05:10 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| EZEKOWITZ ALAN Director | Purchase | Mar 7, 2025 | 117,420 |
| FINER JEFFREY M.D., PH.D. Chief Executive Officer | Conversion of Exercise of derivative security | Apr 3, 2025 | 826,907 |
| LABRUCHERIE GILBERT M JR Chief Financial Officer | Purchase | Feb 27, 2025 | -- |
| RA CAPITAL MANAGEMENT, L.P. Beneficial Owner of more than 10% of a Class of Security | Purchase | Oct 28, 2024 | -- |
| THIRD ROCK VENTURES V, L.P. Beneficial Owner of more than 10% of a Class of Security | Purchase | Oct 28, 2024 | -- |
| THIRD ROCK VENTURES VI, L.P. Beneficial Owner of more than 10% of a Class of Security | Purchase | Feb 24, 2025 | -- |
Related Tickers
MAZE Maze Therapeutics, Inc.
7.83
+3.03%
MBX MBX Biosciences, Inc.
7.41
+18.18%
BCAX Bicara Therapeutics Inc.
10.77
+6.11%
CTNM Contineum Therapeutics, Inc.
4.0100
-2.91%
UPB Upstream Bio, Inc.
7.37
+15.16%
CGEM Cullinan Therapeutics, Inc.
7.71
+1.72%
APGE Apogee Therapeutics, Inc.
31.80
+6.21%
KYTX Kyverna Therapeutics, Inc.
2.0600
+10.16%
IRON Disc Medicine, Inc.
38.73
+9.93%
SION Sionna Therapeutics, Inc.
7.87
+2.74%